Home

expérience fraternité La physique mallinckrodt pharmaceuticals new jersey profond Encore Renaissance

NJBIA, New Jersey Business Magazine Recognize Mallinckrodt Pharmaceuticals  Among Outstanding Redevelopment Projects - Mallinckrodt Pharmaceuticals Blog
NJBIA, New Jersey Business Magazine Recognize Mallinckrodt Pharmaceuticals Among Outstanding Redevelopment Projects - Mallinckrodt Pharmaceuticals Blog

Mallinckrodt Pharmaceuticals | LinkedIn
Mallinckrodt Pharmaceuticals | LinkedIn

News Detail | Mallinckrodt Pharmaceuticals
News Detail | Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals – Real Estate NJ
Mallinckrodt Pharmaceuticals – Real Estate NJ

5 Questions with Elissa Cote, Chief Strategy and Business Development  Officer, Mallinckrodt Pharmaceuticals · BioBuzz
5 Questions with Elissa Cote, Chief Strategy and Business Development Officer, Mallinckrodt Pharmaceuticals · BioBuzz

P3 acquires 233,000 sq. ft. pharma HQ building in Bedminster, C&W says –  Real Estate NJ
P3 acquires 233,000 sq. ft. pharma HQ building in Bedminster, C&W says – Real Estate NJ

News : Shelbourne
News : Shelbourne

Mallinckrodt Pharmaceuticals Specialty Brands Office - New Jersey Business  Magazine
Mallinckrodt Pharmaceuticals Specialty Brands Office - New Jersey Business Magazine

Mallinckrodt Pharmaceuticals Opens Bedminster Office, Adds 330 New Jobs |  Bernardsville, NJ Patch
Mallinckrodt Pharmaceuticals Opens Bedminster Office, Adds 330 New Jobs | Bernardsville, NJ Patch

Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal  Pharmaceuticals LLC | Business Wire
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC | Business Wire

The 2 pharmaceutical giants coming to Central Jersey - nj.com
The 2 pharmaceutical giants coming to Central Jersey - nj.com

Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics  unit | Fierce Pharma
Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit | Fierce Pharma

Mallinckrodt Locates Growing Specialty Brands Businesses In Bedminster, N.J.;  Continues Significant St. Louis Reinvestment
Mallinckrodt Locates Growing Specialty Brands Businesses In Bedminster, N.J.; Continues Significant St. Louis Reinvestment

Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces  $100,000 Donation To Princeton University Program For High Achieving,  Low-Income High School Students
Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students

Mallinckrodt spending $90M on new campus and more manufacturing | Fierce  Pharma
Mallinckrodt spending $90M on new campus and more manufacturing | Fierce Pharma

Mallinckrodt, ensnared in opioid crisis, seeks Chapter 11 | WCIV
Mallinckrodt, ensnared in opioid crisis, seeks Chapter 11 | WCIV

Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt  Pharmaceuticals
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceuticals

New Jersey | Mallinckrodt Pharmaceuticals
New Jersey | Mallinckrodt Pharmaceuticals

Pharma Maker Mallinckrodt Returns Its US Headquarters to Hunterdon County, New  Jersey
Pharma Maker Mallinckrodt Returns Its US Headquarters to Hunterdon County, New Jersey

New Jersey | Mallinckrodt Pharmaceuticals
New Jersey | Mallinckrodt Pharmaceuticals

New Jersey | Mallinckrodt Pharmaceuticals
New Jersey | Mallinckrodt Pharmaceuticals

Mallinckrodt Jobs in October, 2022 (Hiring Now!)
Mallinckrodt Jobs in October, 2022 (Hiring Now!)

Our Story | Mallinckrodt Pharmaceuticals
Our Story | Mallinckrodt Pharmaceuticals

Mallinckrodt to Buy Sucampo Pharmaceuticals for About $840 Million - WSJ
Mallinckrodt to Buy Sucampo Pharmaceuticals for About $840 Million - WSJ

New Jersey | Mallinckrodt Pharmaceuticals
New Jersey | Mallinckrodt Pharmaceuticals

Purdue Pharma and Mallinckrodt in turmoil as opioid settlements mount
Purdue Pharma and Mallinckrodt in turmoil as opioid settlements mount

Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid  crisis | Fierce Pharma
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis | Fierce Pharma